Neuried, Germany

Switch Biotech Ag


USPTO Granted Patents = 6

% Expired Patents = 66.7

Forward Citations = 14

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Andreas Goppelt (3 out of 3 patents)

silverMedal Jörn-Peter Halle (2 out of 2 patents)

bronzeMedal Johannes Regenbogen (2 out of 2 patents)

4.  Heidmarie Peuker (1 out of 1 patent)

5.  Heidemarie Peuker (1 out of 1 patent)

6.  Jörn-Peter Halle (1 out of 1 patent)

7.  Peter Hof (1 out of 1 patent)

8.  Gerhard Maass (1 out of 5 patents)

9.  Christoph Bogedain (1 out of 8 patents)

10.  Markus Hörer (1 out of 1 patent)

11.  Eckard Wolf (1 out of 2 patents)

12.  Sabine Werner (1 out of 1 patent)


6 patents:

Company Overview
Switch Biotech Ag is a biotechnology company focused on developing novel therapeutic molecules for the treatment of cancer and other diseases. The company's innovative approach to drug discovery and development has led to the creation of several promising candidates that are currently in preclinical and clinical trials. With a team of experienced scientists and industry experts, Switch Biotech Ag is dedicated to advancing the field of biotechnology and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#2 in Neuried

#5,401 in Germany

Neuried, DE
Neuried, Germany
Forward Citations = 14

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Switch Biotech Ag. Retrieved from https://idiyas.com/company/switch-biotech-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…